Serial Number | 87717949 |
Word Mark | EVOLVE BIOLOGICS |
Filing Date | Tuesday, December 12, 2017 |
Status | 700 - REGISTERED |
Status Date | Tuesday, March 23, 2021 |
Registration Number | 6297748 |
Registration Date | Tuesday, March 23, 2021 |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, January 5, 2021 |
Certificate of Correction for Registration | In the statement, page 2, line 9, "EVLOVE" should be deleted, and "EVOLVE" should be inserted. |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Disclaimer with Predetermined Text | "BIOLOGICS" |
Description of Mark | The mark consists of the word "EVOLVE" in stylized lettering with the "V" forming into the "O" with the word "BIOLOGICS" underneath the letters "LVE" in stylized format. |
Goods and Services | Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods |
Goods and Services | Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities |
Goods and Services | Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics |
Goods and Services | Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment |
Goods and Services | Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biolotics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 22, 2017 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 037 - Building construction; repair; installation services. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 22, 2017 |
Primary Code | 037 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 22, 2017 |
Primary Code | 040 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 22, 2017 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 22, 2017 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | EVOLVE BIOLOGICS INC. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Mississauga, Ontario L5N 8G6 CA |
Party Name | Therapure Biopharma Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Mississauga, Ontario L5N8H9 CA |
Party Name | Therapure Biopharma Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Mississauga, Ontario L5N8H9 CA |
Event Date | Event Description |
Wednesday, July 7, 2021 | REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD |
Wednesday, July 7, 2021 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
Thursday, July 1, 2021 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Monday, April 19, 2021 | TEAS SECTION 7 REQUEST RECEIVED |
Tuesday, March 23, 2021 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, January 5, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 5, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, December 16, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, December 1, 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Thursday, November 26, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, November 25, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, November 25, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, July 6, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, July 6, 2020 | NON-FINAL ACTION E-MAILED |
Monday, July 6, 2020 | NON-FINAL ACTION WRITTEN |
Thursday, June 25, 2020 | LETTER OF PROTEST EVIDENCE FORWARDED |
Wednesday, February 12, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, February 12, 2020 | NON-FINAL ACTION E-MAILED |
Wednesday, February 12, 2020 | NON-FINAL ACTION WRITTEN |
Tuesday, January 28, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Tuesday, January 14, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Wednesday, January 1, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Monday, December 30, 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
Friday, December 27, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Thursday, December 19, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, December 18, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, December 18, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, December 13, 2019 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Wednesday, November 27, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Wednesday, October 30, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Wednesday, June 19, 2019 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Wednesday, June 19, 2019 | INQUIRY TO SUSPENSION E-MAILED |
Wednesday, June 19, 2019 | SUSPENSION INQUIRY WRITTEN |
Friday, November 30, 2018 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Friday, November 30, 2018 | LETTER OF SUSPENSION E-MAILED |
Friday, November 30, 2018 | SUSPENSION LETTER WRITTEN |
Wednesday, November 7, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, November 7, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, October 30, 2018 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Thursday, May 3, 2018 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, May 3, 2018 | LETTER OF SUSPENSION E-MAILED |
Thursday, May 3, 2018 | SUSPENSION LETTER WRITTEN |
Thursday, May 3, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, May 3, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, May 1, 2018 | ASSIGNED TO LIE |
Tuesday, April 24, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, February 16, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, February 16, 2018 | NON-FINAL ACTION E-MAILED |
Friday, February 16, 2018 | NON-FINAL ACTION WRITTEN |
Wednesday, February 14, 2018 | ASSIGNED TO EXAMINER |
Friday, December 22, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Friday, December 15, 2017 | NEW APPLICATION ENTERED IN TRAM |